iBio
  • CDMO SERVICES
  • THERAPEUTICS AND VACCINES
    • Overview
    • Fibrosis
      • IBIO-100
    • COVID-19
      • IBIO-200 VLP Vaccine
      • IBIO-201 Subunit Vaccine
    • Classical Swine Fever
      • IBIO-400
    • Virus-Like Particles
    • LicKM
  • INVESTORS
  • CAREERS
Contact Us

Press Releases

Investors

Investors

  • Overview
  • Company Info
    • Profile
    • Management Team
  • News & Events
    • Press Releases
    • IR Calendar
  • Stock Info
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Resources
    • IR Contact
    • Email Alerts
    • Investor FAQ
  • News & Events

  • Press Releases
  • IR Calendar
Feb 06, 2020 4:30pm EST

iBio, Inc. Announces Postponement of Annual Meeting

Feb 03, 2020 4:15pm EST

iBio and CC-Pharming Initiate Joint Development of Coronavirus Vaccine

Jan 16, 2020 8:00am EST

iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance

Jan 06, 2020 9:15am EST

iBio Initiates New Litigation Against Fraunhofer

Dec 23, 2019 8:30am EST

iBio Announces Collaboration with EdgePoint AI for Next Gen Quality in Biologics Manufacturing

Dec 16, 2019 4:15pm EST

iBio Reports Progress on its Bio-Better Rituximab Collaboration with CC-Pharming

Dec 13, 2019 5:00pm EST

iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan

Dec 10, 2019 4:44pm EST

iBio Introduces FastGlycaneering Development Service™ to Power Recombinant Protein Production

Dec 03, 2019 12:31pm EST

iBio Joins Manufacturing USA’s Tissue Biofabrication Initiative

Dec 02, 2019 4:15pm EST

iBio to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …11
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed

iBio, Inc.
iBio CDMO, LLC

8800 HSC Pkwy
Bryan, TX 77807


979.446.0027  
info@ibioinc.com

iBio Created with Sketch.

Privacy Policy

Copyright © iBio 2021